Pfizer: Time To Be Fearless


  • The significant drop of over 20% from December highs to last week’s lows left PFE investors nursing their wounds.
  • Pfizer’s underwhelming FY23 outlook still fell short of downgraded analysts’ estimates.
  • With the reset in forward expectations, weak holders have likely fled, igniting the return of long-term buyers seeing opportunities in weakness.

Pfizer Canada head office in Kirkland, Quebec, Canada.


Pfizer Inc. (NYSE:PFE) investors who added more positions at its December highs have seen a significant collapse since then. Accordingly, PFE fell nearly 22% (in price-performance terms) from its December top through its lows last week, as it failed to participate in

PFE price chart (weekly)

PFE price chart (weekly) (TradingView)

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Are you looking to strategically enter the market and optimize gains?

Unlock the key to successful growth stock investments with our expert guidance on identifying lower-risk entry points and capitalizing on them for long-term profits. As a member, you’ll also gain access to exclusive resources including:

  • 24/7 access to our model portfolios

  • Daily Tactical Market Analysis to sharpen your market awareness and avoid the emotional rollercoaster

  • Access to all our top stocks and earnings ideas

  • Access to all our charts with specific entry points

  • Real-time chatroom support

  • Real-time buy/sell/hedge alerts

Sign up now for a Risk-Free 14-Day free trial!

Leave a Reply

Your email address will not be published. Required fields are marked *